FDA Inspection 1195016 — Howard A. Hassman, D.O.

Howard A. Hassman, D.O. — FEI 3016244679

The FDA completed an inspection of Howard A. Hassman, D.O. on Jan 17, 2023 in Marlton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Marlton, NJ (United States)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.